C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 491/044 (2006.01) A61K 31/407 (2006.01) A61K 31/655 (2006.01) A61P 29/00 (2006.01) A61P 31/04 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2723465
Disclosed herein are 6-oxa-2-az-abicyclo[3.2.0]heptane-3,7-dione or heterobicyclic .gamma.-lactam-.beta.-lactone derivatives of formula (I) that include a sulfonate ester, ester or ether group in the substituent at the 4-position as proteasome inhibitors. These Salinosporamide derivatives of formula (I) can be included in pharmaceutical compositions and can be used for treating or ameliorating a disease or condition such as cancer, a microbial disease or inflammation.
La présente invention concerne des dérivés de 6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione ou ?-lactam-ß-lactone hétérobicycliques de formule (I) qui comprennent un groupe ester de sulfonate, ester ou éther dans le substituant en position 4 en tant qu'inhibiteurs des protéasomes. Ces dérivés de salinosporamide de formule (I) peuvent être inclus dans des compositions pharmaceutiques et peuvent être utilisés pour traiter et/ou améliorer une maladie ou une pathologie telle que le cancer, une maladie microbienne et/ou une inflammation.
Chao Ta-Hsiang
Macherla Venkat Rami Reddy
Manam Rama Rao
Mcarthur Katherine A.
Neuteboom Saskia Theodora Cornelia
Barrigar Intellectual Property Law
Nereus Pharmaceuticals Inc.
LandOfFree
Proteasome inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteasome inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteasome inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1645994